Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA)
CUSIP: 152309100
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Ordinary shares, nominal value 0.002 GBP per share
- Shares outstanding
- 154,679,549
- Total 13F shares
- 128,332,503
- Share change
- +4,797,200
- Total reported value
- $3,111,987,564
- Put/Call ratio
- 60%
- Price per share
- $24.25
- Number of holders
- 124
- Value change
- +$147,803,679
- Number of buys
- 57
- Number of sells
- 69
Quarterly Holders Quick Answers
What is CUSIP 152309100?
CUSIP 152309100 identifies CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 152309100:
Top shareholders of CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
|
Company · 10%+ Owner |
13%
|
19,963,157
|
$262,315,883 | — | 30 Jun 2025 | |
| Index Venture Life Associates VI Ltd |
13F
|
Company |
6.4%
|
9,961,789
|
$130,897,907 | — | 30 Jun 2025 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Individual |
6.3%
|
9,681,818
|
$127,219,089 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.4%
|
8,403,000
|
$110,415,420 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.2%
|
6,532,768
|
$85,816,688 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.8%
|
5,907,992
|
$77,632,000 | — | 30 Jun 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3.2%
|
5,000,000
|
$65,700,000 | — | 30 Jun 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.9%
|
4,529,318
|
$59,515,239 | — | 30 Jun 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.8%
|
4,293,411
|
$56,415,421 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
2.5%
|
3,826,194
|
$50,276,189 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
2.2%
|
3,460,029
|
$45,464,781 | — | 30 Jun 2025 | |
| Commodore Capital LP |
13F
|
Company |
2.1%
|
3,298,289
|
$43,339,517 | — | 30 Jun 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1.9%
|
2,890,816
|
$37,985,322 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.7%
|
2,591,596
|
$34,053,571 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
2,543,539
|
$33,422,108 | — | 30 Jun 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.3%
|
2,086,600
|
$27,417,924 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,793,471
|
$23,566,212 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,657,887
|
$21,784,635 | — | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.99%
|
1,529,836
|
$20,102,045 | — | 30 Jun 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.82%
|
1,265,672
|
$16,630,930 | — | 30 Jun 2025 | |
| Foresite Capital Management VI LLC |
13F
|
Company |
0.81%
|
1,253,379
|
$16,469,400 | — | 30 Jun 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.79%
|
1,221,610
|
$16,051,955 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.74%
|
1,146,935
|
$15,070,726 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.73%
|
1,130,708
|
$14,857,530 | — | 30 Jun 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.67%
|
1,030,000
|
$13,534,200 | — | 30 Jun 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.65%
|
1,000,000
|
$13,140,000 | — | 30 Jun 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.58%
|
900,162
|
$11,828,129 | — | 30 Jun 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.54%
|
830,945
|
$10,918,617 | — | 30 Jun 2025 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.51%
|
793,327
|
$10,424,317 | — | 30 Jun 2025 | |
| David J. Grainger |
3/4/5
|
Chief Innovation Officer |
—
class O/S missing
|
990,290
|
$7,882,708 | — | 31 Dec 2023 | |
| Tanager Wealth Management LLP |
13F
|
Company |
0.39%
|
598,044
|
$7,858,298 | — | 30 Jun 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.36%
|
559,744
|
$7,355,036 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
559,283
|
$7,348,979 | — | 30 Jun 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.36%
|
554,803
|
$7,290,111 | — | 30 Jun 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.36%
|
553,292
|
$7,270,257 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.33%
|
510,779
|
$6,711,636 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
0.32%
|
500,000
|
$6,570,000 | — | 30 Jun 2025 | |
| Antoine Yver |
3/4/5
|
EVP & Chairman of Development |
—
class O/S missing
|
783,066
|
$6,233,205 | — | 01 Jun 2023 | |
| Arjun Goyal |
3/4/5
|
Director |
—
mixed-class rows
|
502,585
mixed-class rows
|
$5,886,902 | +$5,865,242 | 20 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.28%
|
428,434
|
$5,629,622 | — | 30 Jun 2025 | |
| Capital World Investors |
13F
|
Company |
0.27%
|
416,823
|
$5,477,054 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.26%
|
400,278
|
$5,259,653 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.26%
|
400,000
|
$5,256,000 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
384,900
|
$5,057,586 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.25%
|
381,125
|
$5,007,982 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.22%
|
347,599
|
$4,567,645 | — | 30 Jun 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.22%
|
344,972
|
$4,532,932 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.22%
|
343,318
|
$4,511,199 | — | 30 Jun 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.21%
|
330,600
|
$4,344,084 | — | 30 Jun 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.21%
|
317,574
|
$4,172,922 | — | 30 Jun 2025 |
Institutional Holders of Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) as of Q3 2025
As of 30 Sep 2025,
Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) was held by
124 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
128,332,503 shares.
The largest 10 holders included
Medicxi Ventures Management (Jersey) Ltd, Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Index Venture Life Associates VI Ltd, GENERAL ATLANTIC, L.P., FMR LLC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, and First Light Asset Management, LLC.
This page lists
124
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
117
Q3 2025 holders
124
Holder diff
7
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.